Fibroblast growth factor 23 inhibits osteoblastic gene expression and induces osteoprotegerin in vascular smooth muscle cells.
暂无分享,去创建一个
Hiroki Matsui | Hiroaki Sunaga | M. Kurabayashi | M. Arai | T. Utsugi | T. Iso | K. Kawai-Kowase | Takehiro Nakahara | Shouichi Tomono
[1] C. Giachelli,et al. A current understanding of vascular calcification in CKD. , 2014, American journal of physiology. Renal physiology.
[2] Su‐Li Cheng,et al. Targeted Reduction of Vascular Msx1 and Msx2 Mitigates Arteriosclerotic Calcification and Aortic Stiffness in LDLR-Deficient Mice Fed Diabetogenic Diets , 2014, Diabetes.
[3] S. Mu,et al. Fibroblast growth factor 23 accelerates phosphate-induced vascular calcification in the absence of Klotho deficiency. , 2014, Kidney international.
[4] M. Rosenfeld,et al. Bone Marrow– or Vessel Wall–Derived Osteoprotegerin Is Sufficient to Reduce Atherosclerotic Lesion Size and Vascular Calcification , 2013, Arteriosclerosis, thrombosis, and vascular biology.
[5] H. Qiu,et al. Osteoprotegerin Inhibits Calcification of Vascular Smooth Muscle Cell via Down Regulation of the Notch1-RBP-Jκ/Msx2 Signaling Pathway , 2013, PloS one.
[6] Kazuyoshi Uchihashi,et al. FGF23-induced hypophosphatemia persists in Hyp mice deficient in the WNT coreceptor Lrp6. , 2013, Contributions to nephrology.
[7] Elena Aikawa,et al. Macrophage-Derived Matrix Vesicles: An Alternative Novel Mechanism for Microcalcification in Atherosclerotic Plaques , 2013, Circulation research.
[8] M. Budoff,et al. Fibroblast growth factor 23 is not associated with and does not induce arterial calcification , 2013, Kidney international.
[9] Yong Sun,et al. Smooth Muscle Cell–Specific Runx2 Deficiency Inhibits Vascular Calcification , 2012, Circulation research.
[10] L. Hsiao,et al. Vascular Klotho Deficiency Potentiates the Development of Human Artery Calcification and Mediates Resistance to Fibroblast Growth Factor 23 , 2012, Circulation.
[11] Xianwu Li,et al. Runx2/Cbfa1, but not loss of myocardin, is required for smooth muscle cell lineage reprogramming toward osteochondrogenesis , 2010, Journal of cellular biochemistry.
[12] C. Chazot,et al. High levels of serum fibroblast growth factor (FGF)-23 are associated with increased mortality in long haemodialysis patients. , 2009, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[13] M. Kurabayashi,et al. Notch Signaling Induces Osteogenic Differentiation and Mineralization of Vascular Smooth Muscle Cells: Role of Msx2 Gene Induction via Notch-RBP-Jk Signaling , 2009, Arteriosclerosis, thrombosis, and vascular biology.
[14] B. Coll,et al. RANKL Increases Vascular Smooth Muscle Cell Calcification Through a RANK-BMP4–Dependent Pathway , 2009, Circulation research.
[15] T. Callister,et al. SCCT guidelines for performance of coronary computed tomographic angiography: a report of the Society of Cardiovascular Computed Tomography Guidelines Committee. , 2009, Journal of cardiovascular computed tomography.
[16] M. Tamura,et al. Bone morphogenetic protein‐2 enhances Wnt/β‐catenin signaling‐induced osteoprotegerin expression , 2009, Genes to cells : devoted to molecular & cellular mechanisms.
[17] M. Wolf,et al. Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. , 2008, The New England journal of medicine.
[18] D. Brancaccio,et al. Vascular Calcification and Uremia: What Do We Know? , 2007, American Journal of Nephrology.
[19] Hiroki Matsui,et al. Runx2 Represses Myocardin-Mediated Differentiation and Facilitates Osteogenic Conversion of Vascular Smooth Muscle Cells , 2007, Molecular and Cellular Biology.
[20] K. Boström,et al. Regulation of Bone Morphogenetic Protein-4 by Matrix GLA Protein in Vascular Endothelial Cells Involves Activin-like Kinase Receptor 1* , 2006, Journal of Biological Chemistry.
[21] Hiroki Matsui,et al. Jagged1-selective Notch Signaling Induces Smooth Muscle Differentiation via a RBP-Jκ-dependent Pathway* , 2006, Journal of Biological Chemistry.
[22] Brian J. Bennett,et al. Osteoprotegerin Inactivation Accelerates Advanced Atherosclerotic Lesion Progression and Calcification in Older ApoE−/− Mice , 2006, Arteriosclerosis, thrombosis, and vascular biology.
[23] R. Quigley,et al. Effect of fibroblast growth factor-23 on phosphate transport in proximal tubules. , 2005, Kidney international.
[24] Y. Takeuchi,et al. FGF‐23 Is a Potent Regulator of Vitamin D Metabolism and Phosphate Homeostasis , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[25] P. Weissberg,et al. Osteo/Chondrocytic Transcription Factors and Their Target Genes Exhibit Distinct Patterns of Expression in Human Arterial Calcification , 2003, Arteriosclerosis, thrombosis, and vascular biology.
[26] R. Aebersold,et al. Smooth Muscle Cell Phenotypic Transition Associated With Calcification: Upregulation of Cbfa1 and Downregulation of Smooth Muscle Lineage Markers , 2001, Circulation research.
[27] S. Morony,et al. osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. , 1998, Genes & development.
[28] D. Lacey,et al. Osteoprotegerin Ligand Is a Cytokine that Regulates Osteoclast Differentiation and Activation , 1998, Cell.
[29] J. Skepper,et al. Calcification of human vascular cells in vitro is correlated with high levels of matrix Gla protein and low levels of osteopontin expression. , 1998, Arteriosclerosis, thrombosis, and vascular biology.
[30] P L Weissberg,et al. Isolation of gene markers of differentiated and proliferating vascular smooth muscle cells. , 1993, Circulation research.
[31] K. Watson,et al. Bone morphogenetic protein expression in human atherosclerotic lesions. , 1993, The Journal of clinical investigation.
[32] S. Abbara. ACCF/SCCT/ACR/AHA/ASE/ASNC/NASCI/SCAI/SCMR 2010 Appropriate Use Criteria for Cardiac Computed Tomography , 2011 .
[33] 大窄マリアナ今日美. Estrogen inhibits vascular calcification via vascular RANKL system : common mechanism of osteoporosis and vascular calcification , 2010 .
[34] 清水 岳久. Notch signaling induces osteogenic differentiation and mineralization of vascular smooth muscle cells : role of Msx2 gene induction via Notch-RBP-Jk signaling , 2009 .
[35] G. Owens,et al. Multiple repressor pathways contribute to phenotypic switching of vascular smooth muscle cells. , 2007, American journal of physiology. Cell physiology.